137 related articles for article (PubMed ID: 12355577)
21. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
Conte JE; Golden JA; McIver M; Zurlinden E
Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
[TBL] [Abstract][Full Text] [Related]
22. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
23. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetics of (-)-clausenamide and its major metabolite 6-hydroxyl-clausenamide in beagle dogs by HPLC/MS].
Song M; Qian W; Hang TJ; Zhang ZX
Yao Xue Xue Bao; 2005 Oct; 40(10):940-4. PubMed ID: 16408814
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
Zhong DF; Li K; Xu JH; Du Y; Zhang YF
Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacokinetics of triptolide in Beagle dogs].
Shao F; Wang GJ; Sun JG; Xie HT; Zhang R; Zhu XY
Yao Xue Xue Bao; 2007 Jan; 42(1):61-5. PubMed ID: 17520809
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of two once-daily parenteral cephalexin formulations in dogs.
Rebuelto M; Montoya L; Kreil V; Ambros L; Waxman S; Albarellos G; Hallu R
J Vet Pharmacol Ther; 2005 Oct; 28(5):419-23. PubMed ID: 16207303
[TBL] [Abstract][Full Text] [Related]
28. Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration.
Rohatagi S; Kan S; Derendorf H
Pharmazie; 1997 Jul; 52(7):529-32. PubMed ID: 9266589
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacokinetics of fudosteine in healthy volunteers].
Ding L; Yang J; Li RS; Zhou M; Shen JP; Zhang YD
Yao Xue Xue Bao; 2005 Oct; 40(10):945-9. PubMed ID: 16408815
[TBL] [Abstract][Full Text] [Related]
30. Disposition of abouthiouzine: a novel antihyperthyroid drug.
Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
[TBL] [Abstract][Full Text] [Related]
31. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
Darwish M; Chang S; Hellriegel ET
Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
[TBL] [Abstract][Full Text] [Related]
32. Clinical pharmacokinetics of lyophilized recombinant human erythropoietin-alpha following single-dose subcutaneous administration in premature newborns.
Melo AM; Costa MT; Porta V; Vaz FA
J Matern Fetal Neonatal Med; 2005 Jan; 17(1):55-8. PubMed ID: 15804788
[TBL] [Abstract][Full Text] [Related]
33. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
Forouzesh B; Takimoto CH; Goetz A; Diab S; Hammond LA; Smetzer L; Schwartz G; Gazak R; Callaghan JT; Von Hoff DD; Rowinsky EK
Clin Cancer Res; 2003 Nov; 9(15):5540-9. PubMed ID: 14654534
[TBL] [Abstract][Full Text] [Related]
34. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
35. The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs.
Cox SR; Lesman SP; Boucher JF; Krautmann MJ; Hummel BD; Savides M; Marsh S; Fielder A; Stegemann MR
J Vet Pharmacol Ther; 2010 Oct; 33(5):461-70. PubMed ID: 20840390
[TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
37. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of ceftiofur hydrochloride in pigs infected with porcine reproductive and respiratory syndrome virus.
Tantituvanont A; Yimprasert W; Werawatganone P; Nilubol D
J Antimicrob Chemother; 2009 Feb; 63(2):369-73. PubMed ID: 19073620
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of PFA (trisodium phosphonoformate) after i.v. and p.o. administration to beagle dogs and rabbits.
Ritschel WA; Grummich KW; Hussain SA
Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):41-8. PubMed ID: 3157841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
